Gland Pharma reported another disappointing quarter with weak revenue growth in its base business. Additionally, Gland Pharma faced further drag from its acquired Cenexi business.
Gland Pharma reported another disappointing quarter with weak revenue growth in its base business. Additionally, Gland Pharma faced further drag from its acquired Cenexi business.